In Vitro and In Vivo Activities of DS-2969b, a Novel GyrB Inhibitor, and Its Water-Soluble Prodrug, DS11960558, against Methicillin-Resistant Staphylococcus aureus

DS-2969b is a novel GyrB inhibitor under clinical development. In this study, the in vitro activity of DS-2969b and the in vivo activities of DS-2969b and its water-soluble prodrug, DS11960558, against methicillin-resistant Staphylococcus aureus (MRSA) were evaluated. DS-2969b inhibited the supercoi...

Volledige beschrijving

Bewaard in:
Bibliografische gegevens
Gepubliceerd in:Antimicrob Agents Chemother
Hoofdauteurs: Barman, Tarani Kanta, Kumar, Manoj, Mathur, Tarun, Namba, Eiko, Singh, Diksha, Chaira, Tridib, Kurosaka, Yuichi, Yamada, Makiko, Upadhyay, Dilip Jatashankar, Masuda, Nobuhisa
Formaat: Artigo
Taal:Inglês
Gepubliceerd in: American Society for Microbiology 2018
Onderwerpen:
Experimental Therapeutics
Online toegang:https://ncbi.nlm.nih.gov/pmc/articles/PMC5971602/
https://ncbi.nlm.nih.gov/pubmed/29610202
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/AAC.02556-17
Tags: Voeg label toe
Geen labels, Wees de eerste die dit record labelt!

Gelijkaardige items